Oracle Investment Management Inc Buys Adaptimmune Therapeutics PLC, Aduro Biotech Inc, Arena Pharmaceuticals Inc, Sells Mazor Robotics, Intrexon Corp, Endologix Inc

• New Purchases: ADRO,
• Added Positions: ADAP, PACB, ARNA, EPZM, CFRX,
• Reduced Positions: MZOR, AMRN, TSRO, QDEL, OPK,
• Sold Out: XON, ELGX, ARAY,

For the details of ORACLE INVESTMENT MANAGEMENT INC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=ORACLE+INVESTMENT+MANAGEMENT+INC

1. Quidel Corp (QDEL) - 2,336,448 shares, 39.96% of the total portfolio. Shares reduced by 2.18%
2. Tesaro Inc (TSRO) - 844,718 shares, 15.94% of the total portfolio. Shares reduced by 5.22%
3. Pacific Biosciences of California Inc (PACB) - 9,537,661 shares, 6.45% of the total portfolio. Shares added by 12.83%
4. Amarin Corp PLC (AMRN) - 5,176,479 shares, 5.14% of the total portfolio. Shares reduced by 17.88%
5. Mazor Robotics Ltd (MZOR) - 246,317 shares, 4.99% of the total portfolio. Shares reduced by 80.95%

Oracle Investment Management Inc initiated holding in Aduro Biotech Inc. The purchase prices were between $6 and $9.3, with an estimated average price of $7.3. The stock is now traded at around $8.15. The impact to a portfolio due to this purchase was 0.73%. The holding were 238,478 shares as of 2018-03-31.

Oracle Investment Management Inc added to a holding in Adaptimmune Therapeutics PLC by 28.79%. The purchase prices were between $6.68 and $11.56, with an estimated average price of $8.7. The stock is now traded at around $12.81. The impact to a portfolio due to this purchase was 1.1%. The holding were 1,330,070 shares as of 2018-03-31.

Oracle Investment Management Inc added to a holding in Arena Pharmaceuticals Inc by 24.07%. The purchase prices were between $30.89 and $44, with an estimated average price of $38.9. The stock is now traded at around $46.69. The impact to a portfolio due to this purchase was 0.44%. The holding were 174,525 shares as of 2018-03-31.

Oracle Investment Management Inc sold out a holding in Intrexon Corp. The sale prices were between $12.01 and $17.1, with an estimated average price of $14.3.

Oracle Investment Management Inc sold out a holding in Endologix Inc. The sale prices were between $3.79 and $5.21, with an estimated average price of $4.29.

Oracle Investment Management Inc sold out a holding in Accuray Inc. The sale prices were between $4.5 and $5.9, with an estimated average price of $5.24.